Research sites & clinicians
The right trial. The right site. A clearer start for all.
trialport helps people understand a clinical trial, consider how it may fit their health and their life, and reach your site with clearer expectations and the right questions.
What your site gains
People arrive with a clearer understanding of the study, what taking part may involve, and the questions they still want to explore. Your team receives the results from medifit™ and readifit™ immediately, giving you earlier insight into potential eligibility questions, practical challenges, concerns, and support needs before the conversation begins.
That means your team can spend less time starting from scratch and more time focusing on what matters for that individual. Potential barriers can be identified earlier, questions can be addressed sooner, and conversations can be more focused and productive.
A small amount of reflection up front can save everyone time later, helping your site focus its effort on people for whom the study may be both medically appropriate and realistically manageable in everyday life.
How it works
People find your site
People find your site and relevant studies through a simple search experience.
They understand and reflect
Plain-language study summaries with medifit + readifit self-reflection tools help people consider how the clinical trial may fit their health and their life.
They connect when ready
When they are ready, trialport connects them directly with your site.
Why trialport?
trialport was shaped by people with more decades of experience running a clinical trial site and more importantly delivering on what we had promised.
We understand the pressure to recruit well, reduce screen failures, manage limited time and make every conversation count. trialport does not replace your processes or clinical judgment. It brings understanding forward, so your team can focus earlier on the questions and support that matter.
FAQs
Frequently asked questions
Does trialport replace our existing site screening processes?
No. trialport is designed to support your existing screening process, not replace it.
The clinical study team always remains responsible for confirming eligibility, conducting any required screening assessments, answering clinical questions, and determining whether someone is suitable to take part in the study.
Before someone connects with your site, trialport helps them understand the study and reflect on both its medical requirements and what participation could mean in their everyday life. medifit™ presents the study’s eligibility criteria through a short self-reflection, while readifit™ helps the person think through practical considerations such as time, travel, appointments, work, family responsibilities, support, and energy.
This means that when your team first speaks with someone, they may already have a better understanding of the study, some of the questions they want to ask, and areas that may need further discussion.
trialport helps prepare the conversation. Your team continues to lead the clinical assessment and screening process.
What information does a site receive?
When someone chooses to connect with your site, you receive the information they have chosen to provide as part of their inquiry.
Where medifit™ and readifit™ have been completed, your team can also see the results of those self-reflections. This can provide useful early context around how the person believes they may align with the study’s eligibility criteria, as well as practical considerations, questions, concerns, or areas where additional support may be helpful.
The information is there to help your team understand the person before the first conversation, rather than having to begin completely from scratch.
Importantly, the information provided by trialport is decision support, not a clinical determination. medifit™ does not confirm eligibility, and readifit™ does not determine whether someone should participate. Those conversations and decisions remain between the person and the clinical study team.
Is there a cost for sites to receive inquiries?
No. There is no cost to the clinical trial site to receive or follow up with inquiries through trialport.
Our aim is to make it easier for interested people and research sites to connect, without creating an additional financial barrier for the site.
Once a person chooses to connect, your team can review the information they have provided and follow your usual processes for contacting them, discussing the study, and determining whether formal screening is appropriate.
Does trialport give our site more work to do?
No. It is designed to do the opposite.
We do ask the appropriate members of your team to log into the trialport portal, because that is where you can securely review the information provided by someone who has made an inquiry, including their medifit™ and readifit™ information where these have been completed.
However, you do not need to keep checking the portal to see whether somebody new has appeared. We notify your team when a new inquiry has been received, so you can log in when there is something that actually requires your attention.
Your team then follows its normal process for contacting the person and, where appropriate, progressing them through site screening.
The difference is that you are beginning that conversation with more information. The person may already understand more about the study, your team may already be able to see potential questions or practical challenges, and both sides can focus sooner on what actually needs to be discussed.
The intention is not to create another administrative task. It is to help make the work you are already doing more informed, focused, and efficient.